INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Advancing Your API To First Human Dose Trials More Efficiently
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Why Flexible Payment Options Matter For Clinical Trial Participants
In clinical trials, offering a variety of payment options is critical for participant retention and overall study success. How can you make the payment process simple and flexible?
-
Harnessing The Potential Of Patient-Level Data In Clinical Trials
Join our panel of industry leaders as they explore innovative methods and best practices for incorporating fully consented patient data in clinical trials.
-
Productivity Hacks For An Effective RFP / Clinical Trial Vendor Selection
Starting a new clinical study requires careful vendor selection and these practical, actionable steps to enhance your selection process and ensure long-term partnership alignment.
-
Designed To Help Sites Increase Clinical Trial Capacity7/25/2025
IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
-
Taking A Concierge Approach To Modern Pharma Meetings12/10/2025
Pharma meetings run smoother when they reflect real site needs. This article breaks down how travel, timing, venue, and training choices strengthen engagement from the start.
-
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept12/17/2025
Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.
-
Relieving The Strain Of Publishing During Regulatory Registration8/7/2024
Go inside how an expertly handled NDA submission for a biopharma company ensured timely FDA approval despite challenges.
-
Planning For High-Performance Hematologic Oncology Clinical Trials5/7/2024
Running successful clinical trials in hematologic malignancies necessitates a deep comprehension of a swiftly evolving treatment framework that is growing more nuanced, intricate, and patient-centered.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
By examining how satisfaction data is gathered, interpreted, and acted upon, we highlight a framework intended to strengthen relationships and enhance service quality.
-
Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.
-
CVRM trials must address comorbidities and complex needs. See how real-world data and expertise improve design, speed recruitment, and advance cardiovascular, renal, and metabolic care.
-
Since our founding, DSG has transformed clinical trial data collection and analysis with its integrated suite of EDC software solutions. Below is a wide range of clinical trials software and services that we offer to our clients.
-
Clinical trials are how new treatments move from the lab to the people who need them most. By joining a study, you’re not only accessing potential new therapies—you’re helping advance medicine for future generations.